Vivien R. Hebert
Rouen, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 60 publications
Daratumumab as a therapeutic option for rituximab-recalcitrant pemphigus.
Journal: The Journal of investigative dermatology
Published: May 18, 2026
Efficacy and Safety of Rituximab in Pemphigus Foliaceus: A Systematic Review and Meta-analysis.
Journal: Dermatology and therapy
Published: March 22, 2026
Tocilizumab for severe and refractory mucous membrane pemphigoid.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: December 04, 2025
Prevalence and pathogenicity of anti-SPCA1 and anti-M3AchR autoantibodies in pemphigus.
Journal: The British journal of dermatology
Published: November 06, 2025
French national protocol for diagnosis and management of pemphigoid gestationis.
Journal: Annales de dermatologie et de venereologie
Published: November 05, 2025
Persistence of anti-Desmoglein 3 Antibodies in Patients with Pemphigus Vulgaris in Clinical Remission is Associated with Restricted Isotype Diversity and Desmoglein 3 Ectodomain Recognition.
Journal: The British journal of dermatology
Published: October 23, 2025
Incidence and mortality of mucous membrane pemphigoid in France.
Journal: The British journal of dermatology
Published: September 28, 2025
Baricitinib and low-dose prednisone for very severe alopecia areata: A retrospective case series.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: June 11, 2025
Incidence of P200 pemphigoid: A nationwide study.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: June 11, 2025
Optimizing Pemphigus Management With Rituximab and Short-Term Relapse Predictors.
Journal: JAMA dermatology
Published: February 05, 2025
Last Updated: 09/26/2026